Sensei Net Interest Income vs Ebit Analysis

SNSE Stock

USD 0.60 0.08 15.38%

Sensei Biotherapeutics financial indicator trend analysis is much more than just breaking down Sensei Biotherapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sensei Biotherapeutics is a good investment. Please check the relationship between Sensei Biotherapeutics Net Interest Income and its Ebit accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sensei Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For information on how to trade Sensei Stock refer to our How to Trade Sensei Stock guide.

Net Interest Income vs Ebit

Net Interest Income vs Ebit Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sensei Biotherapeutics Net Interest Income account and Ebit. At this time, the significance of the direction appears to have pay attention.

The correlation between Sensei Biotherapeutics' Net Interest Income and Ebit is -0.73. Overlapping area represents the amount of variation of Net Interest Income that can explain the historical movement of Ebit in the same time period over historical financial statements of Sensei Biotherapeutics, assuming nothing else is changed. The correlation between historical values of Sensei Biotherapeutics' Net Interest Income and Ebit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Interest Income of Sensei Biotherapeutics are associated (or correlated) with its Ebit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit has no effect on the direction of Net Interest Income i.e., Sensei Biotherapeutics' Net Interest Income and Ebit go up and down completely randomly.

Correlation Coefficient

-0.73

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Net Interest Income

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.

Ebit

Most indicators from Sensei Biotherapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sensei Biotherapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sensei Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For information on how to trade Sensei Stock refer to our How to Trade Sensei Stock guide.As of November 25, 2024, Selling General Administrative is expected to decline to about 12.9 M. In addition to that, Issuance Of Capital Stock is expected to decline to 855.00

	2021	2022	2023	2024 (projected)
Interest Expense	670K	219K	144K	136.8K
Depreciation And Amortization	685K	1.3M	3.7M	3.9M

Interest Expense Depreciation And Amortization

Sensei Biotherapeutics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Short Long Term Debt
Total Assets		-0.09	0.06	0.16	0.98	-0.79	0.89	0.87	-0.94	-0.62	-0.78	0.56	0.69	0.86	-0.87	0.68	-0.72	0.86	0.71	-0.88	0.44	0.95	-0.86	0.98	0.88	0.72
Short Long Term Debt Total	-0.09		-0.3	0.87	-0.09	0.0	-0.03	0.08	0.17	0.56	-0.06	0.28	-0.16	0.1	0.21	-0.26	-0.25	-0.24	0.25	-0.12	-0.29	-0.05	0.06	-0.05	0.08	0.23
Other Current Liab	0.06	-0.3		-0.09	-0.1	0.09	-0.38	-0.24	0.23	-0.05	0.5	0.11	-0.06	-0.26	0.0	0.5	0.11	0.1	-0.07	0.39	0.09	-0.15	0.38	-0.1	-0.26	-0.2
Total Current Liabilities	0.16	0.87	-0.09		0.11	-0.39	0.14	0.23	-0.02	0.23	-0.25	0.64	0.17	0.23	-0.16	-0.01	-0.62	0.04	0.63	-0.21	0.13	0.18	0.0	0.15	0.22	0.59
Total Stockholder Equity	0.98	-0.09	-0.1	0.11		-0.76	0.95	0.88	-0.97	-0.59	-0.83	0.49	0.65	0.88	-0.84	0.62	-0.69	0.84	0.66	-0.94	0.38	0.96	-0.94	1.0	0.89	0.7
Other Liab	-0.79	0.0	0.09	-0.39	-0.76		-0.79	-0.79	0.8	0.76	0.86	-0.83	-0.9	-0.77	0.96	-0.36	0.96	-0.66	-0.96	0.67	-0.83	-0.85	0.6	-0.76	-0.79	-0.97
Net Tangible Assets	0.89	-0.03	-0.38	0.14	0.95	-0.79		0.9	-0.98	-0.61	-0.95	0.48	0.7	0.9	-0.83	0.4	-0.72	0.74	0.69	-0.97	0.43	0.94	-0.96	0.95	0.92	0.76
Property Plant And Equipment Net	0.87	0.08	-0.24	0.23	0.88	-0.79	0.9		-0.92	-0.65	-0.9	0.62	0.82	1.0	-0.84	0.24	-0.73	0.56	0.73	-0.86	0.5	0.95	-0.83	0.88	1.0	0.74
Current Deferred Revenue	-0.94	0.17	0.23	-0.02	-0.97	0.8	-0.98	-0.92		0.71	0.91	-0.49	-0.76	-0.91	0.88	-0.46	0.69	-0.77	-0.67	0.93	-0.49	-0.97	0.94	-0.96	-0.93	-0.71
Net Debt	-0.62	0.56	-0.05	0.23	-0.59	0.76	-0.61	-0.65	0.71		0.66	-0.54	-0.91	-0.64	0.87	-0.2	0.57	-0.46	-0.58	0.41	-0.87	-0.69	0.47	-0.56	-0.65	-0.58
Retained Earnings	-0.78	-0.06	0.5	-0.25	-0.83	0.86	-0.95	-0.9	0.91	0.66		-0.59	-0.8	-0.9	0.85	-0.17	0.81	-0.6	-0.78	0.88	-0.58	-0.9	0.85	-0.83	-0.91	-0.85
Accounts Payable	0.56	0.28	0.11	0.64	0.49	-0.83	0.48	0.62	-0.49	-0.54	-0.59		0.78	0.61	-0.71	0.13	-0.87	0.28	0.89	-0.4	0.73	0.57	-0.27	0.5	0.6	0.84
Cash	0.69	-0.16	-0.06	0.17	0.65	-0.9	0.7	0.82	-0.76	-0.91	-0.8	0.78		0.81	-0.92	0.11	-0.8	0.43	0.81	-0.53	0.9	0.8	-0.51	0.64	0.81	0.8
Non Current Assets Total	0.86	0.1	-0.26	0.23	0.88	-0.77	0.9	1.0	-0.91	-0.64	-0.9	0.61	0.81		-0.83	0.23	-0.71	0.54	0.71	-0.87	0.48	0.94	-0.83	0.87	1.0	0.72
Non Currrent Assets Other	-0.87	0.21	0.0	-0.16	-0.84	0.96	-0.83	-0.84	0.88	0.87	0.85	-0.71	-0.92	-0.83		-0.45	0.86	-0.74	-0.86	0.71	-0.81	-0.92	0.69	-0.83	-0.85	-0.86
Other Assets	0.68	-0.26	0.5	-0.01	0.62	-0.36	0.4	0.24	-0.46	-0.2	-0.17	0.13	0.11	0.23	-0.45		-0.33	0.87	0.31	-0.44	0.09	0.49	-0.45	0.63	0.27	0.3
Long Term Debt	-0.72	-0.25	0.11	-0.62	-0.69	0.96	-0.72	-0.73	0.69	0.57	0.81	-0.87	-0.8	-0.71	0.86	-0.33		-0.61	-1.0	0.65	-0.74	-0.78	0.53	-0.7	-0.73	-1.0
Cash And Short Term Investments	0.86	-0.24	0.1	0.04	0.84	-0.66	0.74	0.56	-0.77	-0.46	-0.6	0.28	0.43	0.54	-0.74	0.87	-0.61		0.57	-0.74	0.34	0.78	-0.74	0.84	0.59	0.61
Common Stock Shares Outstanding	0.71	0.25	-0.07	0.63	0.66	-0.96	0.69	0.73	-0.67	-0.58	-0.78	0.89	0.81	0.71	-0.86	0.31	-1.0	0.57		-0.61	0.75	0.77	-0.49	0.67	0.72	0.99
Non Current Liabilities Total	-0.88	-0.12	0.39	-0.21	-0.94	0.67	-0.97	-0.86	0.93	0.41	0.88	-0.4	-0.53	-0.87	0.71	-0.44	0.65	-0.74	-0.61		-0.21	-0.9	0.98	-0.95	-0.88	-0.68
Other Current Assets	0.44	-0.29	0.09	0.13	0.38	-0.83	0.43	0.5	-0.49	-0.87	-0.58	0.73	0.9	0.48	-0.81	0.09	-0.74	0.34	0.75	-0.21		0.54	-0.19	0.36	0.49	0.73
Other Stockholder Equity	0.95	-0.05	-0.15	0.18	0.96	-0.85	0.94	0.95	-0.97	-0.69	-0.9	0.57	0.8	0.94	-0.92	0.49	-0.78	0.78	0.77	-0.9	0.54		-0.88	0.95	0.96	0.79
Total Liab	-0.86	0.06	0.38	0.0	-0.94	0.6	-0.96	-0.83	0.94	0.47	0.85	-0.27	-0.51	-0.83	0.69	-0.45	0.53	-0.74	-0.49	0.98	-0.19	-0.88		-0.94	-0.85	-0.57
Net Invested Capital	0.98	-0.05	-0.1	0.15	1.0	-0.76	0.95	0.88	-0.96	-0.56	-0.83	0.5	0.64	0.87	-0.83	0.63	-0.7	0.84	0.67	-0.95	0.36	0.95	-0.94		0.89	0.71
Property Plant And Equipment Gross	0.88	0.08	-0.26	0.22	0.89	-0.79	0.92	1.0	-0.93	-0.65	-0.91	0.6	0.81	1.0	-0.85	0.27	-0.73	0.59	0.72	-0.88	0.49	0.96	-0.85	0.89		0.74
Short Long Term Debt	0.72	0.23	-0.2	0.59	0.7	-0.97	0.76	0.74	-0.71	-0.58	-0.85	0.84	0.8	0.72	-0.86	0.3	-1.0	0.61	0.99	-0.68	0.73	0.79	-0.57	0.71	0.74

Click cells to compare fundamentals

Sensei Biotherapeutics Account Relationship Matchups

Sensei Biotherapeutics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.2M	21.4M	153.2M	118.4M	74.4M	67.9M
Short Long Term Debt Total	16.1M	567K	2.4M	8.0M	6.2M	5.1M
Other Current Liab	125K	916K	1.1M	331K	(929K)	(882.6K)
Total Current Liabilities	21.7M	4.8M	4.9M	9.1M	5.6M	6.5M
Total Stockholder Equity	(68.7M)	(56.4M)	146.5M	103.4M	64.9M	68.1M
Property Plant And Equipment Net	268K	1.3M	4.6M	9.7M	7.0M	4.2M
Net Debt	15.8M	(16.0M)	(4.8M)	(9.8M)	(6.8M)	(6.5M)
Retained Earnings	(92.3M)	(112.4M)	(149.2M)	(197.8M)	(231.9M)	(220.3M)
Accounts Payable	3.5M	3.9M	2.5M	4.5M	1.7M	3.1M
Cash	251K	16.6M	7.2M	17.8M	13.0M	10.2M
Non Current Assets Total	715K	1.4M	4.7M	9.8M	7.1M	4.4M
Cash And Short Term Investments	251K	16.6M	147.6M	17.8M	65.8M	45.6M
Common Stock Shares Outstanding	29.3M	30.6M	27.7M	30.7M	28.0M	26.9M
Liabilities And Stockholders Equity	1.2M	21.4M	153.2M	118.4M	74.4M	67.9M
Non Current Liabilities Total	48.2M	73.0M	1.8M	5.9M	3.8M	3.6M
Other Current Assets	251K	3.5M	921K	1.5M	1.5M	1.4M
Other Stockholder Equity	(23.9M)	56.0M	296.0M	302.2M	297.0M	165.4M
Total Liab	69.9M	77.9M	6.7M	15.0M	9.5M	9.0M
Net Invested Capital	(52.6M)	(55.9M)	146.5M	103.4M	64.9M	68.1M
Property Plant And Equipment Gross	268K	1.3M	5.8M	11.2M	8.8M	5.0M
Total Current Assets	502K	20.1M	148.5M	108.6M	67.3M	63.5M
Non Current Liabilities Other	620K	138K	149K	67K	60.3K	57.3K
Net Working Capital	(21.2M)	15.2M	143.7M	99.5M	61.6M	54.5M
Short Term Debt	16.1M	32K	1.4M	4.3M	4.9M	3.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Sensei Biotherapeutics is a strong investment it is important to analyze Sensei Biotherapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sensei Biotherapeutics' future performance. For an informed investment choice regarding Sensei Stock, refer to the following important reports:

How To Invest In Sensei

Details

Is Sensei Stock a good investment?

Details

What is Sensei Biotherapeutics' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sensei Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For information on how to trade Sensei Stock refer to our How to Trade Sensei Stock guide.

You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sensei Biotherapeutics. If investors know Sensei will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sensei Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.19)

Return On Assets

(0.27)

Return On Equity

(0.45)

The market value of Sensei Biotherapeutics is measured differently than its book value, which is the value of Sensei that is recorded on the company's balance sheet. Investors also form their own opinion of Sensei Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sensei Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sensei Biotherapeutics' market value can be influenced by many factors that don't directly affect Sensei Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Sensei Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sensei Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sensei Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sensei Net Interest Income vs Ebit Analysis

Net Interest Income vs Ebit

Net Interest Income vs Ebit Correlation Analysis

Correlation Coefficient

Net Interest Income

Ebit

Sensei Biotherapeutics fundamental ratios Correlations

Sensei Biotherapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Sensei Biotherapeutics fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Invested Capital	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Non Current Assets Total
Short Long Term Debt	+ 0.99	Common Stock Shares Outstanding
Total Stockholder Equity	+ 0.98	Total Assets

Short Long Term Debt	- 1.0	Long Term Debt
Common Stock Shares Outstanding	- 1.0	Long Term Debt
Current Deferred Revenue	- 0.98	Net Tangible Assets
Other Stockholder Equity	- 0.97	Current Deferred Revenue
Non Current Liabilities Total	- 0.97	Net Tangible Assets
Short Long Term Debt	- 0.97	Other Liab